Ray, Riju http://orcid.org/0000-0002-2540-4533
Tombs, Lee
Asmus, Michael J.
Boucot, Isabelle http://orcid.org/0000-0003-0410-4969
Lipson, David A. http://orcid.org/0000-0001-6732-4593
Compton, Chris
Naya, Ian
Funding for this research was provided by:
GlaxoSmithKline
Article History
First Online: 27 June 2018
Compliance with Ethical Standards
:
: All clinical studies included in this pooled analysis were carried out according to the principles of the Declaration of Helsinki and received appropriate ethical approval. Informed consent was obtained for all individual participants included in the studies used as the basis for this pooled analysis.
: RR, CC, IN, IB, DL, and MJA are employees of GSK and hold stocks and shares in GSK. LT is a contingent worker on assignment at GSK. ELLIPTA is owned by or licensed to the GlaxoSmithKline group of companies.
: This study was funded by GSK (GSK study number: 208125). Editorial support (in the form of writing assistance during development of the initial draft, assembling tables and figures, collating authors comments, grammatical editing, and referencing) was provided by Chrystelle Rasamison, at Fishawack Indicia Ltd, UK, and was funded by GSK.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.